Comparison of the Effectiveness of Hydroxyethyl Starch (Voluven) Solution With Normal Saline in Hemorrhagic Shock Treatment in Trauma
| Autor: | Ali Asgari Darian, Arash Forouzan, Alireza Rafaty Navaii, Kambiz Masoumi |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
Resuscitation Hydroxyethyl starch Emergency unit medicine.medical_treatment Trauma Colloidal solution 03 medical and health sciences 0302 clinical medicine Fluid therapy Medicine 030212 general & internal medicine Normal saline Saline business.industry 030208 emergency & critical care medicine General Medicine Surgery Hemorrhagic shock Original Article Base excess business Perfusion medicine.drug |
| Zdroj: | Journal of Clinical Medicine Research |
| ISSN: | 1918-3011 1918-3003 |
| Popis: | Background: Appropriate fluid therapy affects morbidity and mortality rates. A conclusion is yet to be reached on the role of crystalloids and colloids in immediate fluid therapy. This study was done to determine the suitable solution in immediate resuscitation of patients with hemorrhagic shock caused by tissue trauma. Methods: One hundred trauma patients with hemorrhagic shock, who underwent fluid therapy in the emergency unit, were assigned randomly to two groups of hydroxyethyl starch (Voluven) and normal saline. Before and after fluid therapy, 1 cc of blood was taken from all patients in order to determine and compare base excess levels. Results: In hydroxyethyl starch (Voluven) and normal saline groups, base excess level after solution therapy increased about 9.65 and 5.46 volumes, respectively, in which augmentation in hydroxyethyl starch (Voluven) group is significantly higher than normal saline group (P ≤ 0.001). Conclusion: By using hydroxyethyl starch (Voluven) for fluid therapy in hemorrhagic shock caused by trauma, serum base excess decreases and results in improvement in tissue perfusion and better balance in acid-base status and it seems to be superior over normal saline administration, but the building block of the ideal fluid therapy should still remain with the physician’s final clinical judgment. J Clin Med Res. 2016;8(11):815-818 doi: http://dx.doi.org/10.14740/jocmr2702w |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|